Previous close | 1,640.00 |
Open | 1,641.50 |
Bid | 1,606.50 x 0 |
Ask | 1,607.00 x 0 |
Day's range | 1,604.00 - 1,663.00 |
52-week range | 1,125.50 - 1,738.57 |
Volume | 615,167 |
Avg. volume | 726,935 |
Market cap | 6.362B |
Beta (5Y monthly) | 0.82 |
PE ratio (TTM) | 25.72 |
EPS (TTM) | 62.40 |
Earnings date | 26 Mar 2021 |
Forward dividend & yield | 0.47 (2.84%) |
Ex-dividend date | 08 Apr 2021 |
1y target est | 1,664.33 |
Smiths Detection, a global leader in threat detection and security screening technologies, today announces it has been awarded an indefinite-delivery-indefinite-quantity (IDIQ) contract with the U.S. Department of Homeland Security, Customs and Border Protection (CBP). The award includes an initial order for a HCVP™Z60 drive-through X-ray inspection system which will be installed at a Laredo, Texas Border Patrol checkpoint by September 2022.
Smiths Detection, a global leader in threat detection and security screening technologies, today announces that its BioFlash® Biological Identifier has been successfully used by the University of Maryland, Baltimore County (UMBC) to identify airborne SARS-CoV-2 inside their campus in real-time at the point of testing.
Smiths Detection, a global leader in threat detection and security screening technologies, confirms its BioFlash® Biological Identifier is capable of detecting airborne COVID-19 following tests conducted by the University of Oregon, positioning the technology as an effective environmental monitoring tool for use in indoor public spaces.